Business
Dicot Pharma announces the final subscription date for units in the ongoing rights issue
Dicot Pharma announces the final subscription date for units in the ongoing rights issue
About this update from Dicot Pharma Ab
Uppsala, Sweden, May 29, 2026. Thursday, June 4, 2026, is the final day for subscription in Dicot Pharma AB’s (“Dicot Pharma” or “the Company”) ongoing rights issue of units, consisting of shares and warrants of series TO 7, totaling approximately SEK 210 million (“the Offering”). Please note that certain banks and nominees have an earlier deadline for subscription. Holders of unit rights should therefore check with their bank or nominee to see if they are using an earlier deadline for subscription. The last day of trading in unit rights is June 1, 2026.NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE ADDITIONAL REGISTRATION OR OTHER MEASURES.The primary purpose of the Issue is to finance the planned phase 2b study of the drug candidate LIB-01, which is scheduled to begin in the second half of 2026. The subscription period runs through June 4, 2026. Anyone who was registered in the share register on the record date of May 19, 2026, has preferential rights to subscribe for units in the Issue based on the number of unit rights allocated. The last day of trading in unit rights, which grant preferential rights to subscribe for units, is June 1, 2026. It is also possible to express interest in subscribing without unit rights. Allocation of units subscribed for without preferential rights will be made in accordance with the allocation principles set forth in the EU Follow-on Prospectus published by Dicot Pharma on May 19, 2026 (the “Prospectus”).Please note that some banks and nominees will close the registration period for exercising unit rights before June 4, 2026, and may sell unit rights for which the investor has not responded. Therefore, please contact your bank or nominee well in advance to find out which deadlines apply.Subscription procedureThe procedure for subscribing for units in the Rights Issue depends on whether you are a nominee-registered (most common) or a directly registered shareholder. If you are uncertain which category applies to you, please contact your bank.You hold shares through a bank or other nominee (nominee-registered shareholder)Contact your n...